|
11 Companies |
|
4 Products |
|
4 Products |
|
8 Mechanisms of Action |
|
0 Trials |
|
59 News |
|
| «12 |
- Enrollment open: Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability (clinicaltrials.gov) - Sep 4, 2013
P2, N=10, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Not yet recruiting --> Recruiting
- Clinical: Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort (clinicaltrials.gov) - May 22, 2013
P=N/A, N=400, Recruiting, Sponsor: Hospices Civils de Lyon
- Trial completion: Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home (clinicaltrials.gov) - Nov 7, 2012
P=N/A, N=17, Completed, Sponsor: Laboratoire fran
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||| Zemaira (human alpha-1 antitrypsin intravenous) / CSL Behring
Enrollment closed: Extension Study of Zemaira (clinicaltrials.gov) - Oct 31, 2012
P4, N=140, Active, not recruiting, Sponsor: CSL Behring
Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- |||| Zemaira (human alpha-1 antitrypsin intravenous) / CSL Behring
Trial completion: Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency (clinicaltrials.gov) - Oct 31, 2012
P4, N=180, Completed, Sponsor: CSL Behring
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- | alpha-1-antitrypsin inhalation (VR179) / Vectura, Grifols
New P2 trial: Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis (clinicaltrials.gov) - Sep 11, 2012
P2, N=41, Completed, Sponsor: Grifols Therapeutics Inc.
- | Prolastin-C (human alpha1-proteinase inhibitor IV) / Grifols, OrphanPacific
Trial completion: SPARK: Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency (clinicaltrials.gov) - Jul 26, 2012
P2, N=30, Completed, Sponsor: Grifols Therapeutics Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P2 trial: Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability (clinicaltrials.gov) - Jun 6, 2012
P2, N=10, Recruiting, Sponsor: University of North Carolina, Chapel Hill
- Trial completion: QUANTUM-1: The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=49, Completed, Sponsor: Medical University of South Carolina
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis (clinicaltrials.gov) - Jan 28, 2012
P1, N=25, Completed, Sponsor: CSL Behring
Active, not recruiting --> Completed Recruiting --> Completed